(Q48411584)

English

Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?

scientific article published on 13 August 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

0 references

Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice? (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Giuseppe Cabibbo

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Giuseppe Cabibbo

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Irene Bargellini

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Michela Antonucci

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Sara Marceglia

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Valeria Mismas

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

language of work or name

0 references

publication date

13 August 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Future Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

2371-2373

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26270206%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Loco-regional treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Transarterial chemoembolization and sorafenib in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Multimodal approaches to the treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Combination therapy of sorafenib and TACE for unresectable HCC: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Is the efficacy of sorafenib treatment in patients with hepatocellular carcinoma affected by age?

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Long-term results of sorafenib in advanced-stage hepatocellular carcinoma: what can we learn from routine clinical practice?

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.173

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48411584&oldid=1208715098"